Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 1000 iu international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 250 iu international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - factor viii, human recombinant - pdr+solv for soln for inj - 500 iu international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human coagulation factor viii - pdr+solv for soln for inj - 500 international unit - blood coagulation factors

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human coagulation factor viii - pdr+solv for soln for inj - 1000 international unit - blood coagulation factors

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human coagulation factor ii, human coagulation factor vii, human coagulation factor ix, human coagulation factor x, protein c, protein s - pdr+solv for soln for inf - 1000 international unit - blood coagulation factors

Ireland - English - HPRA (Health Products Regulatory Authority)

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 250 international unit - blood coagulation factors

Ireland - English - HPRA (Health Products Regulatory Authority)

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 500 international unit - blood coagulation factors

Ireland - English - HPRA (Health Products Regulatory Authority)

bio products laboratory limited - factor viii (antihaemophilic factor), von willebrand factor - pdr+solv for soln for inj - 1000 international unit - blood coagulation factors

United States - English - NLM (National Library of Medicine)

international laboratories, llc - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - paroxetine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets, usp in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology —clinical trials).  a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets, usp in hospitalized depressed patients have not been adequately studied. the efficacy